" class="no-js "lang="en-US"> David Prior - Medtech Alert
Monday, August 18, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
David Prior

David Prior

About David Prior

Lord Prior of Brampton was Parliamentary Under Secretary of State at the Department for Business, Energy and Industrial Strategy from 21 December 2016 to 27 October 2017. Previously he served at the Department of Health as Minister for NHS Productivity from May 2015 until December 2016. He is a Conservative member of the House of Lords.

Related Story

Appointments

 Amanda Pritchard Appointed NHS Chief Executive | Pharmtech Focus

Amanda Pritchard Appointed NHS Chief Executive

July 29 2021

Amanda Pritchard has today been appointed as the new Chief Executive Officer of NHS England. […]